Capricor Receives DoD Grant to Develop Therapeutic Exosome Production Process
The Defense Department has awarded Capricor Therapeutics a $2.4 million grant to develop a process to produce cardiosphere-derived cell exosomes. Capricor said Monday it plans to file an investigational new drug application with the Food and Drug Administration in 2017 for the use of CAP-2003 to treat ocular graft-versus-host disease. “As we advance and expand our exosomes program, this grant […] More